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Lymphocytes (PBMC) obtained from blood of HIV-sera negative Ethiopian immigrants (ETH) were highly susceptible to
HIV-1 infection in vitro with no need for stimulation by mitogens. As the HIV nef gene product has been shown to enhance
viral replication in stimulated primary lymphocytes, we investigated in this work the role of Nef in viral replication in the ETH
cells. Lymphocytes obtained from ETH individuals supported high replication of wild-type HIV-1 and low but significant
replication level of the two deleted Nef mutants (encode truncated Nef proteins consisting only of either the first 35 or the
first 86 amino acids of Nef). In contrast, no replication was observed in nonactivated cells obtained from non-ETH individuals.
After activation of the PBMC from ETH individuals with PHA, replication of both wild-type strains and the two deleted Nef
mutant viruses further increased. The CD4 T cells of ETH individuals exhibited elevated levels of the surface activation
markers CD45RO and HLA-DR, compared with T cells derived from non-ETH group. Likewise, expression of the chemokine
receptors CCR5 and CXCR4 on these cells was higher in the ETH group than in the non-ETH group. Replication of HIV-1
wild-type and the isogenic-deleted Nef mutants was significantly correlated with the proportion of ETH cells expressing
CD45RO and the chemokine receptors. This study suggests that HIV-1 may respond differently to several activation states
characteristic of T cells. One activation state, defined by chronically activated lymphocytes from ETH individuals, is
permissive to the wild-type HIV-1 and, to a lesser degree, to the Nef mutants. Further activation of these cells by exogenous
stimuli enhances replication of the virus. Our results support the notion that Nef enhances the basal level of T cell activationINTRODUCTION
The issue of HIV-1 disease progression in Africa is
controversial; earlier reports from Africa suggested a
faster course of HIV infection with shorter period of
survival after the onset of AIDS (Anzala et al., 1995;
Mbaga et al., 1990). However, more recent reports, based
on a large incidental cohort in rural Uganda, did not find
significant differences in HIV disease progression and
mortality than similar cohorts in the West (Morgan and
Whitworth, 2001; Morgan et al., 2002a,b). Recent studies
have implicated immune cell activation, blood level of
secreted inflammatory cytokines, and chemokines with
frequencies of HIV-1 infection and subsequently with the
rate of disease progression (Mellors et al., 1995; Panta-
leo et al., 1994; Safrit and Koup, 1995; Rizzarde et al.,
1996, 1998; Bentwich et al., 1995; Messele et al.,. 2001).
We have previously reported that fresh lymphocytes
isolated from healthy new immigrants of Ethiopian (ETH)
origin were highly susceptible to HIV-1 infection in cul-
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138ture, with no need for stimulation by immune cell activa-
tors, such as phytohemagglutinin (PHA). In contrast, lym-
phocytes obtained in parallel from non-Ethiopian (non-
ETH) individuals could be productively infected only
following activation by standard T cell activators such as
PHA (Shapira-Nahor et al., 1998). Analysis of T cell sur-
face markers in fresh peripheral blood mononuclear
cells (PBMC) of the two populations has indicated a
striking increase of activated CD4 cells (HLA-DR) in
the ETH group as compared with the non-ETH group
(Shapira-Nahor et al., 1998; Messele et al., 1999). This
chronic activation state of the T-lymphocytes could ex-
plain the ETH susceptibility to HIV-1 infection.
To further study the state of activation of T cells de-
rived from ETH individuals and the correlation with sus-
ceptibility to HIV-1 infection, we investigated, in the
present study, infection of PBMC from ETH individuals by
HIV-1 mutants, carrying frameshift mutations in the nef
gene. The nef gene encodes for an N-terminal modified
myristilated protein that is found associated with raft
structures in the inner surface of the plasma membrane
of the infected cells (Wang et al., 2000; Kaminchik et al.,and consequently, viral replication. © 2002 Elsevier Science (US
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1994). Several groups have studied the role of Nef in
lentiviral replication, using both quiescent and activatedA)
ctivatio
T cells. The nef gene, which is dispensable for HIV-1
replication in T cell lines, enhances viral replication in
primary stimulated lymphocytes (De Ronde et al., 1992;
Spina et al., 1994; Miller et al., 1994). This property of Nef
is especially evident when stimulation by PHA is carried
out subsequent to the time of infection, rather than by the
standard activation protocols, i.e., cell stimulation prior to
infection (Siekevitz et al., 1987; Tong-Starksen et al., 1987;
Ott et al., 1997). Expression of the nef gene in primary
lymphocytes has also been shown to play a positive role
in T cell activation, by lowering the threshold of activation
through the T cell receptor (Schrager and Marsh, 1999;
Rhee and Marsh, 1994; Alexander et al., 1997). Moreover,
recent studies have demonstrated that expression of Nef
mediated superinduction of IL-2 and subsequent activa-
tion of NFB transcription factor (Wang et al., 2000;
Schrager and March, 1999). Since HIV, through the nef
gene, modulates the activation state of the infected cells
and thus may regulate its own replication, it was of
interest to analyze specifically the phenotype of Nef in T
cells displaying different activation states. With this aim
in mind, we investigated the replication of two strains of
HIV-1 and their isogenic-deleted Nef mutants in PBMC of
ETH individuals. We demonstrate in this study that there
is a direct correlation between the activation state of T
cells and extent of HIV-1 replication.
RESULTS
Replication of HIV-deleted Nef mutants
Our previous studies with lymphocytes obtained from
ETH individuals indicated that productive HIV-1 replica-
tion in vitro occurred without a need of mitogenic stim-
ulation. The present study was designed to examine
whether mutations introduced in the nef gene of two
X4-tropic HIV-1 strains of different clades, LAI (clade B)
and ELI (clade D), would affect infection of the ETH
lymphocytes. The mutations in nef were frameshift mu-
tations leading to the expression of truncated proteins
consisting of either the first 35 amino acids of Nef plus 11
missense residues (Nef1) or the first 86 amino acids of
Nef with two missense residues (Nef2) (Melanie et al.,
1995). PBMC were obtained from 42 ETH individuals
(during the first week of their arrival to Israel) and from 6
non-ETH individuals. As can be seen in Fig. 1, at 3, 6, and
9 days postinfection, the deleted Nef mutant viruses
replicated in the PBMC of ETH donors to some extent,
albeit low compared with their wild-type (wt) counter-
parts. The two different deleted Nef mutants manifested
similar phenotypes, i.e., an 8- to 10-fold reduction in virus
production compared with the parental (wt) strains.
Since the extent of T cell activation may play a critical
role in HIV-1 replication, we next analyzed infection of the
HIV-1-deleted Nef mutants following PHA treatment of
PBMC obtained from ETH individuals. Interestingly, we
found that chronically activated cells of ETH could be
further enhanced by PHA treatment to support three- to
fourfold higher replication of the wt HIV, as compared to
nontreated ETH cells (Fig. 2A). This phenomenon is even
more pronounced after infection of ETH lymphocytes
with the deleted Nef mutants (Fig. 2B). While low-level
p24 production was observed without PHA treatment,
some 40- to 200-fold enhancement is observed following
PHA pretreatment (Fig. 2B). A completely different pat-
tern of infection is observed with PBMC of the non-ETH
individuals. As observed previously, the replication of wt
virus is dependent upon cell activation (Fig. 2C). The
HIV-deleted Nef mutants could replicate in the non-ETH
cells only after treatment with PHA, although to a lower
extent than the wt virus (Fig. 2D).
Analysis of the T cell activation profile in correlation
with HIV-1 replication
The activation markers of T cells in chronically acti-
vated PBMC from the ETH and non-ETH donors partici-
pating in this study were measured by flow cytometry.
Results of flow cytometry analysis of 11 ETH of 42 and 6
non-ETH individuals are presented in Table 1. Also in-
cluded is the level of replication of LAI, LAInef1, and
LAInef2 in untreated PBMC of the same individuals.
There is a significant correlation between the extent of
replication of the two deleted Nef mutants and the pro-
portion of CD45RO cells in the PBMC from ETH donors.
For example, donors 3, 4, and 5 have a range of CD45RO
CD4 cells of between 84 and 88% and HIV-1 p24 levels of
5.6–6.7 (ng/mL) for LAInef1 and 6.9–7.2 (ng/mL) for LAI-
nef2 (see Table 1, noted in asterisks).
Statistical analysis of lymphocyte surface markers in-
dicated that the proportion of CD4 lymphocytes that
expressed the CD45RO marker was higher in the ETH
group (42 donors) than in the non-ETH group (6 donors)
(63.4  2.17% vs 41.5  1.9%, P  0.0001), respectively
FIG. 1. Efficiency of infection of PBMC obtained from ETH with two
strains of HIV-1, LAI (f) and ELI (), and with the isogenic deleted Nef
mutants, LAI nef-1 (p), LAI nef-2 (`), ELI nef-1 (o), and ELI nef-2 (z).
Culture supernatants were tested for their p24 levels 3, 6, and 9 days
after infection. The error bars represent the mean values  SD of the
mean of five independent experiments.
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(Fig. 4). Regression analysis of the correlation between
the proportion of CD45ROCD4 cells and the replica-
tion of the wt HIV-1 LAI showed a significant correlation
(Fig. 3A, r2  0.4637, P  0.021). Similarly, the proportion
of CD45ROCD8 cells also showed a significant cor-
relation with replication of the wt HIV-1 LAI (Fig. 3B, r2 
0.4100, P  0.0338).
Expression of CD45RO antigen on CD4 cells was
significantly correlated not only with the replication of wt
HIV-1 virus but also with the two deleted Nef mutants
LAInef1 (r2  0.9116, P 0.0001) (Fig. 3C) and LAInef2 (r2
 0.9464, P  0.0001). Similarly, the proportion of
CD45ROCD8 cells was significantly correlated with
the replication of LAInef1 (r2  0.6485, P  0.0028) (Fig.
3D) and with that of LAInef2 (r2  0.7395, P  0.0007).
The proportion of CD8 cells that expressed the acti-
vation marker CD38 (Messele et al., 1999; Ramazaoui et
al., 1995) was higher among the ETH group than in the
non-ETH group (P  0.029). No significant correlation
was found, however, between HIV-1 replication and the
proportion of CD38CD8 cells.
Analysis of CCR5 and CXCR4 expression
We found that CD4 T cells of both ETH and non-ETH
individuals expressed both the CCR5 and the CXCR4
coreceptors (Fig. 4). However, the proportion of CD4
cells expressing CXCR4 was significantly higher in the
ETH group (42 donors) than the non-ETH group (6 do-
nors): 27.9  3.0% vs 12.74  1.4% (P  0.0001), respec-
tively. Also, the proportion of CD4 cells expressing
CCR5 was higher in the ETH group (18 donors) than the
CD4 cells expressing CCR5 in the non-ETH group (6
donors), 19.54  1.46% vs 9.75  2.39% (P  0.002),
respectively (Fig. 4). We also found a significant correla-
tion between the proportion of CD4 cells expressing
CD45RO and/or the activation marker HLA-DR and the
chemokine receptors CXCR4 and/or CCR5 in the ETH
group (P  0.001).
DISCUSSION
The present study confirms and extends previous ob-
servations, indicating that without addition of a mitogenic
stimulus, wild-type HIV-1 replicated well in PBMC from
ETH individuals. In parallel, T cells of the same ETH
individuals exhibited elevated levels of the activation
marker HLA-DR and had a higher proportion of memory
T (CD45RO) cells than cells of non-ETH donors. The
chronic immune-activation state of the lymphocytes from
the ETH population was strongly associated with intes-
tinal helminthic infections (Shapira-Nahor et al., 1998).
Furthermore, expression of the chemokine receptors
CXCR4 and CCR5, the two major HIV-1 coreceptors, were
higher in the T cells from ETH donors than those from
non-ETH donors. Expression of the chemokine receptors
CCR5 and CXCR4 and replication of wt HIV-1LAI signifi-
cantly correlated with the proportions of cells expressing
CD45RO, both among the CD4 and the CD8 cells.
Multiple steps during HIV-1 productive infection of T
cells may require an immune activation state. First, cell-
surface recognition, as well as penetration of the virus, is
dependent on CD4 as well as the coreceptors CXCR4 or
CCR5 (Alkhatib et al., 1997; Zheng et al., 1996; Picard et
al., 1997). Results of this study, as well as a previous
study (Kalinkovich et al., 2001), clearly indicated that T
FIG. 2. Efficiency of infection with wt LAI (A, C) or with the deleted mutants LAI nef-1 and nef-2 (B, D), in the absence (—F—, —E—) or after
prestimulation with PHA (—f—, ——), respectively. The error bars represent the mean values  SD of the mean of three independent
experiments.
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cells of ETH individuals overexpress the two coreceptors
and this may account, at least in part, for the permissive-
ness of their cells to HIV-1 infection, in the absence of an
exogenous stimulus. Second, early steps of viral replica-
tion, reverse transcription, and nuclear transport of the
proviral DNA are suboptimal following infection of rest-
ing lymphocytes (Folks et al., 1986; Bukrinsky et al., 1991)
and may also be enhanced in the chronically activated
ETH lymphocytes. Finally, and perhaps most important
for HIV RNA transcription, is the activation of the cellular
transcription factor NFB in the stimulated lymphocyte
(Nabel and Baltimore, 1987; Wang et al., 2000). While the
optimal level of immune activation required for each of
these phases of the viral life cycle is not known at this
stage, our data indicate that viral replication is higher in
the chronically activated T cells from ETH donors, ex-
pressing the highest level of activation markers (Table 1).
Mitogenic stimuli elicit T cell activation by setting into
motion a cascade of intracellular events. Nuclear pro-
teins that regulate early T cell activation genes include
activator protein-1 (AP-1), octamer factor-1 (Oct-1), and
particularly NFB, which binds to DNA sequences within
the promotors of interleukin-2 (IL-2) and IL-2 receptor
genes (Emmel et al., 1989; Grilli et al., 1993). Activation of
NFB, a critical element in T cell stimulation (Bours et al.,
1992; Grilli et al., 1993), is in turn regulated by the ZAP-
70/SLP-76 pathways (Herndon et al., 2001). The regula-
tion of NFB activation by ZAP-70 is controlled by yet
another factor Vav-1 (Costello et al., 1999). Differences
were found in the response of T cells to stimuli that were
administered through the T cell receptors (TCR) as com-
pared with stimuli that bypass these receptors. Thus,
while activation of T cells, mediated through the T cell
receptors, elicited a strong activation of NFB, activation
of T cells by lectins was a relative weak inducer of the
NFB (Tong-Starksen et al., 1987; Emmel et al., 1989).
Results of the present study indicate that chronic ac-
tivation of T cells, as found in ETH individuals, renders
the lymphocyte susceptible to some degree of replica-
tion of wt HIV-1 and its isogenic deleted Nef mutants.
Additional stimulation of the cells by short-term exposure
to PHA further augments the susceptibility of the cells to
TABLE 1
T Cell Activation Markers in PBMCs from ETH and non-ETH Donors, and Comparison to HIV-I Replication in These Cells
T cell surface markers (%)
HIV replication
p24 (ng/ml)
CD4 CD3 CD8
CD45RA/
CD8
CD45RO/
CD8
CD38/
CD8
CD45RA/
CD4
CD45RO/
CD4
HLA-DR/
CD4
LAI
wt
LAI
Nef1
LAI
Nef2
Donor ETH
1 45.0 88.0 37.2 60.3 58.6 19.3 37.3 64.7 11.2 48.0 3.3 3.6
2 44.0 78.0 36.6 70.7 40.0 13.5 41.4 64.6 10.8 64.0 1.8 2.3
3 35.5 78.0 36.0 63.3 51.7 35.4 37.8 66.0 13.4 26.0 2.0 2.9
4 34.1 86.1 44.0 63.6 71.1 20.0 27.3 84.6* 18.1 64.0 5.0** 7.0**
5 21.4 90.5 62.0 70.6 60.2 52.1 22.6 88.0* 15.8 68.0 5.6** 7.2**
6 43.5 94.0 42.5 61.9 52.9 31.8 20.5 86.7* 17.6 54.0 6.7** 6.9**
7 39.5 71.0 33.0 77.1 15.1 25.3 54.0 48.0 11.7 40.0 0.2 0.2
8 36.6 72.0 41.0 65.8 23.9 18.4 34.2 67.2 9.8 32.0 2.1 2.6
9 36.5 79.3 42.5 77.7 22.1 30.0 43.0 54.0 12.4 32.0 0.4 0.3
10 37.0 81.0 48.4 92.2 14.7 17.0 40.0 68.0 12.2 40.0 1.8 2.0
11 35.0 72.0 38.0 83.8 13.4 28.8 59.0 51.0 11.1 32.0 0.3 0.2
Mean 37.1 80.9 41.9 71.5 38.5b 26.5 37.9 67.5c 13.1 45.5 2.7 3.2
SDa 6.5 7.8 7.9 10.1 21.3 11.0 11.9 13.9 2.8 15.0 2.2 2.7
Donor non-ETH
1 36.6 58.9 27.7 86.4 12.3 19.2 70.9 37.9
2 45.2 62.7 23.5 98.7 15.6 12.6 68.8 43.7
3 40.4 56.3 16.9 82.7 16.4 18.9 61.3 40.2
4 42.3 61.7 33.1 82.7 23.3 20.1 65.2 50.2
5 38.6 61.7 22.7 65.4 40.8 14.5 65.8 39.2
6 27.9 55.5 22.9 68.8 45.7 22.0 64.6 38.1
Mean 38.5 59.5 24.5 80.8 25.7b 17.9 66.1 41.5a
SD 6.0 3.0 5.4 12.2 14.1 3.6 3.4 4.7
* High levels of CD45ROCD4 cells.
** High levels of replication of HIV-1 deleted Nef mutants.
a SD, values are means  standard deviation.
b P  0.001 as compared to CD45RA/CD8.
c P  0.001 as compared to CD45RA/CD4 (ANOVA).
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HIV-1 infection. At present it is unknown which pathways
in the chronically activated ETH cells are responsible for
these effects.
The susceptibility of lymphocytes to HIV-1 infection
may also depend upon the expression of CXCR4 and
CCR5 chemokine receptors. CCR5 and CXCR4 are differ-
entially expressed on memory vs naı¨ve cells (Bleul et al.,
1997). Among CD4 cells, CCR5 was almost completely
confined to the CD45RO/CD62L memory subset but
was absent from the CD45RA/CD62L subset (Lee et al.,
1999). In HIV-1-infected ETH individuals the level of both
CCR5 and CXCR4 was found to be elevated on CD4
cells of the ETH group (Kalinkovich et al., 2001 and
present study). The elevated levels of both CCR5 and
CXCR4, the HIV-1 coreceptors, could contribute to the
increased susceptibility of ETH lymphocytes to HIV-1
infection.
How does Nef enhance HIV-1 replication? Some ex-
perimental evidence has indicated that the nef gene
product is involved in reducing the threshold of T cells for
activation by exogenous stimuli (Luria et al., 1991; Nied-
erman et al., 1992; Greenway et al., 1995; Collette et al.,
1996; Iafrate et al., 1997; Gulizia et al., 1997). Alternatively,
Nef expression may cause a low level of chronic cell
activation even without a mitogenic stimulus (Zaunders
et al., 1999). In addition, Nef has multiple functions af-
fecting viral replication through mechanisms not neces-
sarily related to T cell activation (Miller et al., 1994; Wang
et al., 2000; Geleziunas et al., 2001). It has been shown,
for example, that Nef expressed in nonlymphoid cells
enhances the reverse transcription of proviral DNA
(Skowronski et al., 1993; Baur et al., 1994) and down-
regulates several expressed cell-surface receptors, i.e.,
CD 4 and HLA class I (Garcia and Miller, 1991). It was of
interest, therefore, to study replication of HIV-1-deleted
Nef mutants in the chronically activated PBMC from ETH
individuals as compared with those from non-ETH indi-
FIG. 3. Correlation between the activation marker CD45RO/CD4 in ETH cells and the efficiency of replication of HIV-I wt LAI (A) or LAI-deleted
Nef mutant (C). Correlation between the activation marker CD45RO/CD8 in ETH cells and the efficiency of replication of HIV-I wt LAI (B) or
LAI-deleted Nef mutant (D). The linear correlation coefficients (r) and the significance (p) are described under Results.
FIG. 4. Expression of the surface antigens CD45RA and CD45RO and
the chemokine receptors CCR5 and CXCR4 on CD4 cells of ETH group
and of non-ETH group. The cells were stained with fluorescence-
labeled mAb against the above surface markers and were classified
using the flow cytometer. Statistically significant differences were
found between the ETH and non-ETH groups (P  0.002; for details,
see Results).
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viduals. As the Nef protein has several apparent func-
tions mediated by different sequence domains, we chose
in this work to delete the nef gene, such that only a short
peptide is expressed, lacking of all known functions
(Wang et al., 2000). Since we have detected some repli-
cation of the nef-deleted virus in ETH lymphocytes, none
of the known functions of Nef appears critical for virus
replication in these cells. In the cells from ETH donors
there was a low but significant replication of the HIV-1-
deleted Nef mutants. Stimulation of PBMC from ETH
donors by PHA further enhanced replication of the HIV-
1-deleted Nef mutants. In parallel, as expected, no rep-
lication of wt HIV-1 and the two deleted Nef mutants was
observed with unstimulated PBMC from non-ETH do-
nors. Taken together, our results suggest that the virus
may respond to several activation states characteristic of
T cells. One activation state, defined by the chronically
activated lymphocytes present in the ETH population,
allows the replication of the wild-type virus and to a
lesser degree the deleted Nef mutants. These results are
compatible with the notion that Nef enhances the level of
T cell activation and consequently it promotes viral rep-
lication.
The viruses used in this study only use the CXCR4
coreceptor. Similar results would presumably be ex-
pected using the R5 viruses since, as showed in the
results, the ETH lymphocytes expressed elevated levels
of CCR5 coreceptor, indicating that there is no obvious
restriction for infection with the R5 virus. Furthermore, if
there will be a restriction, it is probably due to an in-
creased production and secretion of  chemokines by
the activated cells that might specifically block R5 virus
replication.
MATERIALS AND METHODS
Human subjects
The study population consisted of two groups of indi-
viduals, 50 HIV-1-negative ETH and 6 HIV-1-negative
non-ETH. The ETH individuals participating in this study
arrived in Israel as immigrants, between the years 1999
and 2001, and blood was collected during the first week
of their arrival.
PBMC
Blood from HIV-1-negative individuals was layered
onto a Lymph-prep solution (Nycombed, Oslo, Norway)
and spun at 2000 rpm for 20 min. The interlayer contain-
ing PBMC was collected and washed twice with PBS.
PBMC (106/ml) were cultured (75-ml flasks, Coastar,
Cambridge, MA) in RPMI 1640 medium, supplemented
with 20% FCS (Gibco Co.), 1 mM glutamine, penicillin (0.6
g/ml), and streptomycin (60 g/ml).
Molecular clones of HIV-1 and deleted Nef mutants
The infectious molecular clones of the T cell tropic
HIV-1 strains LAI and ELI1 have been described (Peden
et al., 1991), as have the Nef mutants of these viruses
LAInef1, LAInef2, ELI1nef1, and ELI1nef2 (Melanie et al.,
1995). The mutations in the nef gene are frameshift
mutations at the XhoI site (nef1) or the BglII site (nef2),
resulting in proteins comprising the first 35 amino acids
of Nef followed by 11 missense residues for the Nef1
protein and the first 86 amino acids with two missense
residues for the Nef2 protein (named deleted Nef mu-
tants).
HIV infectivity assay
Viral stocks were generated from the infectious clones
by transfection of HEK 293 cells and were used for
infection of PBMC as described previously (Shapira-Na-
hor et al., 1997). Briefly, equivalent quantities of virus,
normalized by reverse transcriptase activity (4  105 RT
cpm), were absorbed to 106/ml PBMC (prepared as de-
scribed above) for 2 h at 37°C, and then the cells were
diluted in 5 ml enriched RPMI. At approximately 3-day
intervals, the cells were fed with RPMI and 10% FCS and
samples (1 ml) were taken for p24 antigen determina-
tions.
For lymphocyte activation, cells were cultured in the
presence of PHA (2.5 g/ml, Sigma Chemical Co., St.
Louis, MO) for 2–3 days before virus infection (Shapira-
Nahor et al., 1997).
Quantitation of virus replication
Quantitation of virion-associated p24 antigen released
into culture supernatants assessed virus production.
Samples of 1 ml were taken from each culture (5 ml) at
the indicated times and stored at70°C until completion
of the experiment. Batch assays for p24 antigen were
performed by the enzyme-linked immunosorbent assay
(ELISA) method (Organon Teknika, Boxtel, NL). Superna-
tants from uninfected cell cultures were included as
negative controls. The concentration of p24 released in
the culture supernatants was calculated by interpolation
of the optical density (405 nm) values of the viral samples
with a standard p24 antigen curve, both measured con-
currently with the same ELISA apparatus.
Immunofluorescent assay and FACS analysis
Cell suspensions, at a volume of 50 l (5  105 cells),
were stained with the following labeled monoclonal an-
tibodies (mAbs): fluorescein isothiocyanate (FITC)-anti-
CD8, FITC-anti-CD4, phycoerythrin (PE)-anti-CD3, PE-
anti-CD38, PE-anti-CD45RA, PE-anti-CD45RO, PE-anti-
CCR5, PE-anti-HLA-DR (Pharmingen, San Diego, CA),
and PE-anti-CXCR4 (R&D Systems Inc., MN). The cells
were incubated with FITC and/or PE-conjugated mAbs
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(10–50 l) against various surface antigens. After 30 min
of incubation at 4°C, the cells were washed twice with
PBS containing 0.1% BSA and 0.1% NaN3. Thereafter, they
were fixed in a solution of 1% paraformaldehyde in PBS
and stored at 4°C until analysis on a FACScan flow
cytometer (Becton-Dickinson) using the Consort 30 pro-
gram. Double immunofluorescent staining was deter-
mined by two-color flow cytometry using the contour-
staining program of Consort 30.
Statistical analysis
The results of HIV-1 infection and T cell activation
markers are presented as the mean values  SD of the
mean of a number of independent experiments. The
results of CXCR4 and CCR5 are presented as the mean
values  SEM. The data were evaluated statistically
using the paired or unpaired Student’s t test and the
Mann–Whitney rank sum test; P values  0.05 were
considered significant. Linear correlation analysis was
performed using SigmaPlot and SigmaStat (Jandel, San
Rafael, CA).
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